98%
921
2 minutes
20
Objective: The Audit of Diabetes-Dependent Quality of Life (ADDQoL) is a widely used instrument for assessing quality of life in Type 2 Diabetes Mellitus (T2DM). However, it does not directly yield health utility values essential for economic evaluations. This study developed mapping algorithms to predict EQ-5D-5L and SF-6Dv2 utility values from ADDQoL scores in T2DM patients in China.
Methods: Cross-sectional data from 800 T2DM patients in China, stratified by age, sex, and geographical region, were divided into development (80%) and validation (20%) groups. Pearson correlation analyses were conducted to assess the conceptual overlap between ADDQoL and the EQ-5D-5L and SF-6Dv2. Six predictor sets and six regression methods were explored to map ADDQoL scores to EQ-5D-5L and SF-6Dv2 utility values, respectively. Model performance was evaluated using mean absolute error (MAE), root mean square error (RMSE), and intraclass correlation coefficient (ICC).
Results: For the development group, the mean (SD) ADDQoL Average Weighted Impact (AWI) score was - 2.426 (1.052), and the mean (SD) utility values for EQ-5D-5L and SF-6Dv2 were 0.928 (0.092) and 0.791 (0.133), respectively. Among all 36 alternative mapping models each for EQ-5D-5L and SF-6Dv2, the best performance was consistently observed in the two-part models that included the ADDQoL AWI, the first overview item, and their squared terms. For the algorithm mapping to EQ-5D-5L utility values, it achieved a MAE of 0.067, a RMSE of 0.095, and an ICC of 0.414; For the algorithm mapping to SF-6Dv2 utility values, the corresponding metrics were an MAE of 0.099, an RMSE of 0.120, and an ICC of 0.517.
Conclusions: This study provides a mapping framework to estimate EQ-5D-5L and SF-6Dv2 utility values from ADDQoL scores. These algorithms could be used to support economic evaluations, specifically tailored for Chinese T2DM populations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12044720 | PMC |
http://dx.doi.org/10.1186/s12955-025-02371-1 | DOI Listing |
Eur J Health Econ
August 2025
School of Public Health, Fudan University, 130 Dong An Road, Shanghai, 200032, China.
Objectives: To compare the measurement properties between EQ-5D-5L/SF-6Dv2 and QLU-C10D utilities, and to assess the implications of their adoption in QALY estimation in hematologic cancer patients.
Method: Longitudinal data of Chinese lymphoma and myeloma patients were adopted. Utility scores of the three instruments were calculated based on a variety of country-specific value sets.
Health Qual Life Outcomes
July 2025
Health Economics Unit, Department of Clinical Sciences (Malmö), Forum Medicum, Lund University, Sölvegatan 19, Lund, 223 62, Sweden.
Background: Measuring health-related quality of life (HRQoL) in dialysis patients is essential for clinical assessment and economic evaluation. Despite the emergence and increasing use of updated instruments, evidence comparing their performance in Chinese dialysis patients remains limited. The aim of this study was to compare the measurement properties of the EQ-5D-5L and the SF-6Dv2 instruments in Chinese patients on dialysis and to provide a reference for future utility scale choice for Chinese dialysis patients.
View Article and Find Full Text PDFHealth Qual Life Outcomes
April 2025
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Objective: The Audit of Diabetes-Dependent Quality of Life (ADDQoL) is a widely used instrument for assessing quality of life in Type 2 Diabetes Mellitus (T2DM). However, it does not directly yield health utility values essential for economic evaluations. This study developed mapping algorithms to predict EQ-5D-5L and SF-6Dv2 utility values from ADDQoL scores in T2DM patients in China.
View Article and Find Full Text PDFPharmacoeconomics
August 2025
Health Outcomes Research Unit, University Hospital of Psychiatry II, Medial University of Innsbruck, 6020, Innsbruck, Austria.
Background: The Quality of Life Utility - Core 10 Dimensions (QLU-C10D) is a disease-specific preference-based measure (PBM) designed to obtain health state utility values from patients with cancer. Previously, satisfactory psychometric properties were established from retrospective trial analyses using clinical anchors. This study aimed to validate the QLU-C10D against two generic PBMs in a prospective sample of Austrian and French patients with cancer using patient-reported anchors.
View Article and Find Full Text PDFValue Health
August 2025
Department of Health Policy, Corvinus University of Budapest, Budapest, Hungary.
Objectives: The Modified EQ Health and Wellbeing (EQ-HWB) and its shorter version (EQ-HWB-S) are new health and well-being measures nearing finalization. Since the 2022 version, the development group has proposed revisions to the item order, response levels, and wording. This study aimed to assess the psychometric properties of the modified Simplified Chinese EQ-HWB and EQ-HWB-S and compare their performance with other measures.
View Article and Find Full Text PDF